Evidence map›Paper›PMID 39590766›Full record

ArticleMarine drugs2024

Incorporation of Silver into Sulfate Groups Enhances Antimicrobial and Antiviral Effects of Fucoidan.

Akira Iwata, Mayuko Yamamoto-Fujimura, Suzuka Fujiwara, Saya Tajima, Takahide Shigeyama, Moriya Tsukimoto, Tatsuya Ibuki, Akito Kataoka-Kato

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Akira IwataYakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo 186-8650, Japan.
Mayuko Yamamoto-FujimuraYakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo 186-8650, Japan.
Suzuka FujiwaraYakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo 186-8650, Japan.
Saya TajimaYakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo 186-8650, Japan.
Takahide ShigeyamaYakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo 186-8650, Japan.
Moriya TsukimotoYakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo 186-8650, Japan.
Tatsuya IbukiYakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo 186-8650, Japan.
Akito Kataoka-KatoYakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo 186-8650, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has significantly impacted our daily lives. Routine infection-control measures present an effective preventive strategy for a new infectious disease outbreak. Fucoidan, a fucose-rich sulfated polysaccharide found in brown algae, exhibits antiviral activity. Moreover, fucoidan exerts an antimicrobial effect; however, it requires considerably higher concentrations than those needed for its antiviral effect. In this study, we aimed to enhance the antimicrobial activity of fucoidan and prepared a fucoidan silver salt (Ag-Fuc) by incorporating silver ions into the sulfate groups of Yakult Fucoidan derived from

Indexed as

Antiviral AgentsPolysaccharidesSilverAnimalsAnti-Bacterial AgentsAnti-Infective AgentsCOVID-19 Drug TreatmentEscherichia coliHumansMicrobial Sensitivity TestsPhaeophyceaeSARS-CoV-2Staphylococcus epidermidisSulfatesAnti-Bacterial AgentsAnti-Infective AgentsAntiviral AgentsfucoidanPolysaccharidesSilverSulfatesantibacterial activityantifungal activityantiviral activityfucoidaninfluenza virusSARS-CoV-2silver

Identifiers

PMID39590766
PMCPMC11595838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.